Purchase Order HHSF223201610488A
- Not listed
- This is a $229,200.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Unchained Labs, LLC, doing business as Optim, a for-profit biotechnology manufacturer. The contract, which has a set-aside for small businesses, is for the delivery of the "FFPHUNK PROTEIN PLATFORM" to support the FDA's "HUNK PROTEIN STABILITY PLATFORM" program. Unchained Labs specializes in advanced scientific instrumentation, equipment, and services for government...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $120,500.00 firm-fixed-price purchase order contract to Unchained Labs, LLC (doing business as Optim) for its UNCLE PLATFORM product. This contract was set aside for small businesses. Unchained Labs is a biotechnology research company that provides scientific instrumentation, equipment, and services to federal agencies such as HHS, the Department of Veterans Affairs, and the Department of Agriculture...
- This federal contract award from the Food and Drug Administration (FDA) was granted to Unchained Labs, LLC, doing business as Optim, to provide a Fluorescence Protein Thermal Stability Measuring Instrument (Unit). The $151,375.00 firm fixed-price purchase order did not have a set-aside designation. Unchained Labs is a biotechnology research company that specializes in advanced scientific instrumentation, equipment, and services for government research programs, particularly supporting efforts in...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Unchained Labs, LLC, a biotechnology research company operating under the trade name Optim. The contract is for the delivery of a laboratory instrument with a potential value of $178,259.50 and a completion date of May 24, 2024. Unchained Labs is a for-profit organization and manufacturer that has received numerous prime federal...
- This is a $18,165.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Unchained Labs, LLC (doing business as Optim), a for-profit manufacturer of biotechnology research equipment and services. The contract is for a service agreement to provide Unchained Labs' UNCLE (Automated Protein Characterization) platform. The award does not utilize any set-aside...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Unchained Labs, LLC, a biotechnology research company doing business as Optim. The $131,041.00 contract has a completion date of February 8, 2024 and does not have a set-aside designation. Unchained Labs provides scientific instrumentation, equipment, and services to support research efforts in areas such as...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order contract to Unchained Labs, LLC, doing business as Optim, for a Big Tuna Automated Liquid Handling System. The contract has a potential value of $248,500.00 and a completion date of September 30, 2020. Unchained Labs is a for-profit biotechnology research company that provides scientific instrumentation, equipment, and services to government customers,...
- The U.S. Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to Unchained Labs, LLC, a biotechnology research company doing business as Optim, for the provision of software applications. The contract has a potential value of $257,449.00 and a completion date of July 26, 2021. The contract was not set aside for a specific business size or type. Unchained Labs, LLC has previously provided scientific...
- The Department of Health and Human Services Food and Drug Administration awarded a definitive contract valued at $814,426.75 to Unchained Labs, LLC doing business as Optim. The contract is for the delivery of an Automated Biologic Formulation Analyzer over a three-year period of performance ending March 2023. The place of performance is Silver Spring, Maryland. This firm fixed price contract has a total small business set aside designation. Optim will provide the FDA with the requested...
- This contract award is for an annual service agreement and software license support for Unchained Labs' Big Kahuna Customized Automated Workflow and Junior Benchtop Automation Platform. The award, valued at $62,318.00, was made by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract has a 12-month period of performance and does not have a set-aside...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Unchained Labs, LLC, doing business as Optim, for the delivery of the HUNK protein stability predictor software. The contract has a ceiling value of $222,160.00 and was awarded on August 31, 2016, with a completion date of August 30, 2021. The contract does not have a set-aside designation. Unchained Labs, LLC is a for-profit biotechnology research company that specializes in advanced scientific instrumentation, equipment, and services for government research programs, primarily serving agencies such as the Department of Health and Human Services, Department of Veterans Affairs, and Department of Agriculture. The company has provided a wide range of specialized laboratory equipment and associated services to the FDA and other federal agencies through its federal contract awards.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
The FDA is looking to purchase an automated protein stability analyzer that is capable of quantifying and predicting protein stability across a wide range of biochemical conditions. | RFQ-FDA-1162905 | Department of Health and Human Services Food and Drug Administration | Award Notice 1/1 | 5/23/16, 1:01 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Exercise an Option | $14.8k | 2/23/17 | |
| 1 | Other Administrative Action | $0 | 1/26/17 | |
| Not listed | Not listed | $163.0k | 8/31/16 |